• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Emerging Technology Market
    Emerging Technology News
    Emerging Technology Stocks
    • Emerging Technology Market
    • Emerging Technology News
    • Emerging Technology Stocks
    robotics investing

    Eli Lilly and Strateos Launch Remote-controlled Robotic Cloud Lab

    Danielle Edwards
    Jan. 09, 2020 05:53AM PST
    Emerging Technology

    Eli Lilly and Strateos have revealed a robotically-controlled laboratory in California designed to speed up the drug discovery process.

    Eli Lilly and Company (NYSE:LLY) and Strateos have entered the pharmaceutical sector after revealing a robotically-controlled laboratory in San Diego, California designed to speed up the drug discovery process.

    As quoted in the press release:

    The Lilly Life Sciences Studio lab was conceptualized and designed by Lilly as part of a $90 million investment made in 2017 to expand Lilly’s research footprint in San Diego. Strateos will utilize their robotic cloud platform to enable the access of this remote-controlled lab to other drug discovery companies and research scientists through its secure cloud-based platform as part of the collaboration.

    The studio lab physically and virtually integrates several areas of the drug discovery process together—including design, synthesis, purification, analysis, sample management, and hypothesis testing—into a fully automated platform. The studio lab will be operated on the Strateos (formerly Transcriptic) technology platform which enables research scientists to remotely control their experiments via a web-based interface. The integrated system gives scientists the benefit of running and refining experiments in real-time with a high degree of reproducibility.

    Click here to read the full press release.

    nyse:llyrobotics investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Surgeons stand around a hospital bed with patient on it and a surgical robot above it.

    8 Surgical Robotics Stocks

    Robot with stock chart.

    Robotics Stocks: 7 Biggest Companies

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Emerging Technology Stocks

    ETCT ROBO Global Robotics and Automation Index ETF

    ROBO:US
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×